Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Retatrutide for Sale > Retatrutide Peptide Material with Batch Specific Identity Documentation CAS 2381089-83-2
Retatrutide Peptide Material with Batch Specific Identity Documentation CAS 2381089-83-2 buy - large image1
Retatrutide Peptide Material with Batch Specific Identity Documentation CAS 2381089-83-2 buy - image1
Retatrutide Peptide Material with Batch Specific Identity Documentation CAS 2381089-83-2 buy - image2
Retatrutide Peptide Material with Batch Specific Identity Documentation CAS 2381089-83-2 buy - image3
Retatrutide Peptide Material with Batch Specific Identity Documentation CAS 2381089-83-2 buy - image4
Retatrutide Peptide Material with Batch Specific Identity Documentation CAS 2381089-83-2 buy - image5
Retatrutide Peptide Material with Batch Specific Identity Documentation CAS 2381089-83-2 buy - image6

Retatrutide Peptide Material with Batch Specific Identity Documentation CAS 2381089-83-2

6832 Inquiries

Unit Price:

$110/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Reagent Grade

Content:

99%

Port:

Shanghai

Brand:

Ascent

Packaging:

1 g/bottle, 5 g/bottle, 10 g/bottle; customized gram-scale and bulk packaging available.

Price valid (until):

2026-10-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Semaglutide,Tirzepatide,Cagrilintide,Cosmetic Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Product Overview

    Research-Grade Peptide Raw Material for Analytical and Nonclinical R&D

    Product Name

    Retatrutide

    Synonym

    LY3437943

    CAS Number

    2381089-83-2

    Product Category

    Research Peptide Raw Material

    Appearance

    White to off-white lyophilized powder

    Purity

    ≥98% or ≥99%, subject to batch specification

    Supply Scale

    Gram-scale and larger project quantities

    Counter-Ion

    TFA, acetate or project-specific form available

    Documentation

    Batch-specific COA, HPLC and MS

    Packaging

    Sealed raw-material container, multilayer foil pouch or custom packaging


    Form note: CAS information is provided for identification. Confirm the required salt or counter-ion form before ordering.

    Product Overview

    Retatrutide, also known as LY3437943, is an investigational peptide designed as a single-molecule agonist of the GIP, GLP-1 and glucagon receptors. Its multi-receptor profile makes it a valuable research material for studying receptor selectivity, signalling balance, peptide engineering and metabolic pathway interactions.


    ASCENT supplies Retatrutide as a peptide raw material for analytical, laboratory and nonclinical research. It is not supplied as a finished drug product, injection, kit or consumer-use formulation.


    Shop Retatrutide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2381089-83-2-Detailed Image 1 Shop Retatrutide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2381089-83-2-Detailed Image 2 Shop Retatrutide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2381089-83-2-Detailed Image 3 Shop Retatrutide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2381089-83-2-Detailed Image 4 Shop Retatrutide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2381089-83-2-Detailed Image 5 Shop Retatrutide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2381089-83-2-Detailed Image 6 Shop Retatrutide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2381089-83-2-Detailed Image 7 Shop Retatrutide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2381089-83-2-Detailed Image 8


    Mechanism and Research Value

    Retatrutide activates the receptors for glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and glucagon. Its triple-receptor activity provides a useful platform for investigating how receptor balance influences downstream signalling and metabolic responses.

    Research interest includes multi-agonist peptide design, comparative receptor pharmacology, structure-activity relationships, lipidated peptide engineering, albumin-binding strategies and analytical characterization of complex modified peptides.


    Core Research Applications

    • GIP, GLP-1 and glucagon receptor signalling research
    • Multi-receptor agonist and receptor-balance studies
    • Peptide structure-activity relationship research
    • Analytical method development and impurity profiling
    • HPLC and mass-spectrometry method verification
    • Peptide stability and degradation studies
    • Comparative research involving single, dual and triple receptor agonists
    • Development of custom peptide sequences and modified analogues

    ASCENT Supply Advantages

    • Batch-specific COA, HPLC and MS data are available for each released batch.
    • Testing for peptide content, water, counter-ion and residual TFA may be arranged according to project requirements.
    • Custom purity, counter-ion, packaging and quantity requirements can be discussed before production.
    • Scale-up support is available for qualified research and development projects.

    Information to Include in Your Inquiry

    Please specify the required quantity, purity, counter-ion, analytical documents, packaging and destination country so that ASCENT can prepare an accurate quotation and technical response.

    FOR RESEARCH AND DEVELOPMENT USE ONLY. NOT FOR HUMAN OR VETERINARY USE, CLINICAL USE, PHARMACY COMPOUNDING, FORMULATION OR ADMINISTRATION.


    Frequently Asked Questions

    Can I request a sample before placing a bulk order? Yes. Sample and small-quantity requests can be evaluated according to current stock and the requested specification. 

    What quality documents are available? Batch-specific COA, HPLC and MS reports can be provided according to the agreed specification. If additional test items are required, please confirm them before placing the order.

    What package sizes can you supply? Common vial sizes include 5 mg, 10 mg, 15 mg, 20 mg, 30 mg and 60 mg. Other quantities and packaging formats can be discussed according to availability and the buyer's requirements.

    What is the minimum order quantity? The minimum order quantity depends on the selected package size and available batch. Sample quantities, individual vials and regular order quantities can be discussed with our sales team.

    Can I use my own label or customized packaging? Customized labels and packaging can be evaluated. Please provide the label artwork, package format, quantity and destination requirements for confirmation before production or packing.

    How are lead time and shipping arranged? Lead time and shipping options depend on stock status, order quantity, destination and the selected transportation method. Please provide the destination country and postal code for an accurate quotation and delivery estimate.

    How should unopened Retatrutide be stored? The unopened lyophilized material should generally be stored at -20°C or below in a dry, tightly sealed container protected from light. The storage information on the product label and batch COA should take priority.

    What information should I provide for a quotation? Please provide the required quantity, preferred vial size, destination country, required quality documents and any label or packaging requirements. Complete information helps us prepare a faster and more accurate quotation.

    Is this product intended for human use? No. This product is supplied strictly for laboratory research, analytical testing and related non-clinical applications. It is not intended for human consumption, medical diagnosis, therapeutic use, clinical applications or veterinary use.


    Research Use Disclaimer

    This product is supplied strictly for laboratory research, analytical testing and related non-clinical applications. It is not intended for human consumption, medical diagnosis, therapeutic use, clinical applications or veterinary use.

    The purchaser is responsible for ensuring that the product is handled and used in accordance with applicable laws, regulations and laboratory safety requirements.


    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Other Chemical Drugs

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Semaglutide,Tirzepatide,Cagrilintide,Cosmetic Peptides

    Location:

    ROOM 203, 2ND FLOOR, BUILDING 2, NO. 265 CHENGRUI STREET, XIASHA STREET, QIANTANG DISTRICT, HANGZHOU CITY, ZHEJIANG PROVINCE,CHINA 310020

    Payment Terms:

    TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2022

    Founded in 2022 and based in Qiantang District, Hangzhou, Zhejiang Province, China, ASCENT is a global supplier of specialty ingredients serving the pharmaceutical, biotechnology, food, nutrition, cosmetic, and personal care industries.

    Our portfolio includes active pharmaceutical ingredients (APIs), peptides, pharmaceutical intermediates, food additives, and cosmetic ingredients. We work with pharmaceutical and biotechnology companies, research institutions, food and nutrition businesses, cosmetic brands, manufacturers, formulation developers, distributors, and professional buyers worldwide.

    At ASCENT, we believe that better ingredients provide the foundation for better products. By combining reliable products, professional support, and efficient supply solutions, we help our customers simplify international sourcing, advance product development, and bring new ideas closer to market.

  • Inquiry History
    6832 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.